Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Qi Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4725-4625; OpenAlex author ID A5100615096. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 3 papers

Papers 4

  1. 5-Year survival rate over 20 % in pancreatic ductal adenocarcinoma: A retrospective study from a Chinese high-volume center. Co-author DOI 10.1016/j.canlet.2025.217658↗
  2. Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial. Co-author DOI 10.1016/j.ccell.2025.09.009↗
  3. Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activation. Last author DOI 10.1016/j.jconrel.2025.114187↗
  4. Modified-FOLFIRINOX in metastatic pancreatic cancer: A prospective study in Chinese population. Co-author DOI 10.1016/j.canlet.2017.07.012↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Risheng Que · 3 shared papers, 2017–2025 · strength 0.45
  2. Guoliang Qiao · 2 shared papers, 2025 · strength 0.39
  3. Xiang Li Ma · 2 shared papers, 2025 · strength 0.39
  4. Tianan Jiang · 2 shared papers, 2025 · strength 0.39
  5. Tingbo Liang · 2 shared papers, 2025 · strength 0.39
  6. Xueli Bai · 2 shared papers, 2025 · strength 0.39
  7. Xiaobao Wei · 1 shared paper, 2025 · strength 0.20
  8. Jiangchao Wu · 1 shared paper, 2025 · strength 0.20
  9. Mengyao Dai · 1 shared paper, 2025 · strength 0.20
  10. Zhe Zhang · 1 shared paper, 2025 · strength 0.20
  11. Yi Zang · 1 shared paper, 2025 · strength 0.20
  12. Tingbo Liang · 1 shared paper, 2025 · strength 0.20
  13. Ting-Bo Liang · 1 shared paper, 2017 · strength 0.05
  14. Ying Yuan · 1 shared paper, 2017 · strength 0.05
  15. Xiang Li · 1 shared paper, 2017 · strength 0.05
  16. Tao Ma · 1 shared paper, 2017 · strength 0.05
  17. Lei Zheng · 1 shared paper, 2017 · strength 0.05
  18. Ri-Sheng Yu · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.